AVNIT KAUR: Open Payments
NPI 1437711769 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,023 in 78 payments from 7 companies in 2025. Trend: 2023 $1,640 · 2024 $1,284 · 2025 $2,023
Food & beverage: $2,023
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $838 |
| Janssen Biotech, Inc. | 17 | $695 |
| Lilly USA, LLC | 11 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $180 |
| PFIZER INC. | 2 | $52 |
| Sandoz Inc. | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: TREMFYA, RINVOQ, SKYRIZI, OMVOH, ENTYVIO, VELSIPITY, XELJANZ, HYRIMOZ.
Industry payments across NY — which companies pay providers there.
